CAS 52232-67-4
:Teriparatide
- Teriparatide Acetate
- Forteo
- L-Phenylalanine, L-seryl-L-valyl-L-seryl-L-alpha-glutamyl-L-isoleucyl-L-glutaminyl-L-leucyl-L-methionyl-L-histidyl-L-asparaginyl-L-leucylglycyl-L-lysyl-L-histidyl-L-leucyl-L-asparaginyl-L-seryl-L-methionyl-L-alpha-glutamyl-L-arginyl-L-valyl-L-alpha-glutamyl-L-tryptophyl-L-leucyl-L-arginyl-L-lysyl-L-lysyl-L-leucyl-L-glutaminyl-L-alpha-aspartyl-L-valyl-L-histidyl-L-asparaginyl-, acetate (salt) hydrate
- L-Seryl-L-valyl-L-seryl-L-alpha-glutamyl-L-isoleucyl-L-glutaminyl-L-leucyl-L-methionyl-L-histidyl-L-asparaginyl-L-leucylglycyl-L-lysyl-L-histidyl-L-leucyl-L-asparaginyl-L-seryl-L-methionyl-L-alpha-glutamyl-L-arginyl-L-valyl-L-alpha-glutamyl-L-tryptophyl-L-leucyl-L-arginyl-L-lysyl-L-lysyl-L-leucyl-L-glutaminyl-L-alpha-aspartyl-L-valyl-L-histidyl-L-asparaginyl-L-phenylalanine acetate (salt) hydrate
- Parathar
- Parathar acetate
- L-Phenylalanine, L-seryl-L-valyl-L-seryl-L-alpha-glutamyl-L-isoleucyl-L-glutaminyl-L-leucyl-L-methionyl-L-histidyl-L-asparaginyl-L-leucylglycyl-L-lysyl-L-histidyl-L-leucyl-L-asparaginyl-L-seryl-L-methionyl-L-alpha-glutamyl-L-arginyl-L-valyl-L-alpha-glutamyl-L-tryptophyl-L-leucyl-L-arginyl-L-lysyl-L-lysyl-L-leucyl-L-glutaminyl-L-alpha-aspartyl-L-valyl-L-histidyl-L-asparaginyl-, acetate (salt)
Parathyroid Hormone (1-34), human
CAS:Parathyroid Hormone (1-34), humanFormula:C181H291N55O51S2Molecular weight:4117.7pTH (1-34) (human)
CAS:Teriparatide, which consists of the N-terminal 34 amino acid residues of parathyroid hormone, shows the same potency and pharmacological profile as the native hormone. Administration of teriparatide stimulates bone formation and increases the bone mineral density (BMD).Formula:C181H291N55O51S2Purity:99.1%Color and Shape:WhiteMolecular weight:4117.77pTH (1-34) (human)
CAS:Intermittent administration of teriparatide stimulates bone formation by increasing the number of osteoblasts. Agonist of the parathyroid hormone receptor PTH1.Formula:C181H291N55O51S2Purity:96.3%Color and Shape:WhiteMolecular weight:4117.77TERIPARATIDE FOR SYSTEM SUITABILITY CRS
CAS:TERIPARATIDE FOR SYSTEM SUITABILITY CRSFormula:C13H14ClNOMolecular weight:235.7094TERIPARATIDE CRS
CAS:TERIPARATIDE CRSFormula:C13H14ClNOColor and Shape:Added AddedMolecular weight:235.7094Teriparatide
CAS:Polypeptide, protein and glycoprotein hormones, their derivatives and structural analogues, nesoiFormula:C181H291N55O51S2Color and Shape:White Off-White PowderMolecular weight:4115.13094Teriparatide acetate
CAS:Formula:C181H291N55O51S2Purity:99%Color and Shape:SolidMolecular weight:4117.7151Teriparatide
CAS:Teriparatide is an agonist of PHT(IC50 of 2 nM in HEK293 cells).Formula:C181H291N55O51S2Purity:98%Color and Shape:SolidMolecular weight:4117.72Parathyroid Hormone Fragment (1-34)- 24,d3 TFA Salt
CAS:Controlled ProductStability Hygroscopic
Applications Parathyroid Hormone Fragment (1-34)-24,d3,TFA Salt is the labeled (on Leucine-d3, position 24) analogue of Parathyroid Hormone Fragment (1-34) (P192200), which is a fragment of human parathyroid hormone (hPTH) peptide sequence containing the 34 N-terminal residues of hPTH. This fragment was also found to be an agonist at PTH1 and PTH2 receptors.
References Niall, et al.: Proc. Natl. Acad. Sci., 71, 384 (1974); Dobnig,T., et al.: Endocrinol., 138, 4607 (1997); Manabe. et al.: Bone., 40, 1475 (2007);Formula:C181D3H288N55O51S2·xC2O2HF3Color and Shape:NeatMolecular weight:4234.8Parathyroid Hormone Fragment (1-34)
CAS:Controlled ProductApplications A fragment of human parathyroid hormone (hPTH) peptide sequence containing the 34 N-terminal residues of hPTH. This fragment was also found to be an agonist at PTH1 and PTH2 receptors.
References Niall, et al.: Proc. Natl. Acad. Sci., 71, 384 (1974); Dobnig,T., et al.: Endocrinol., 138, 4607 (1997); Manabe. et al.: Bone., 40, 1475 (2007);Formula:C181H291N55O51S2Color and Shape:NeatMolecular weight:4117.72Teriparatide-d10
CAS:Controlled ProductFormula:C181D10H281N55O51S2Color and Shape:NeatMolecular weight:4127.72Parathyroid Hormone (Human, 1-34)
CAS:This product which is available as a 0.5mg vial is amino acids 1-34 of the 84 amino acid parathyroid hormone (PTH) and can be used as an adenylate cyclase and bone growth stimulating peptide. It is possible that in can be used in research in the treatments of some types of osteoporosis. PTH is a peptide hormone that is secreted from the parathyroid gland in the event of abnormal serum calcium levels and it ultimately regulates calcium and phosphate levels in the body. The PTH exerts its activity through binding to the G-protein coupled receptor type 1 PTH receptor, which activates adenylate cyclase or phospholipase C thus activating pathways involved in the mediation of bone resorption and bone formation. This product is suitable for life science applications.Formula:C181H291N55O51S2Purity:Min. 95%Molecular weight:4,117.7 g/molParathyroid Hormone (Human, 1-34)
CAS:This product which is available as a 0.1mg vial is amino acids 1-34 of the 84 amino acid parathyroid hormone (PTH) and can be used as an adenylate cyclase and bone growth stimulating peptide. It is also an effective anabolic agent used in the treatment of some forms of Osteoporosis. PTH is a peptide hormone that is secreted from the parathyroid gland in the event of abnormal serum calcium levels and it ultimately regulates calcium and phosphate levels in the body. The PTH exerts its activity through binding to the G-protein coupled receptor type 1 PTH receptor, which activates adenylate cyclase or phospholipase C thus activating pathways involved in the mediation of bone resorption and bone formation. This product is suitable for life science applications.Formula:C181H291N55O51S2Purity:Min. 95%Molecular weight:4,117.7 g/molTeripaRatide Acetate
CAS:Custom research peptide; min purity 95%. For different specs please use the Peptide Quote Tool
Formula:C181H291N55O51S2Molecular weight:4,117.8 g/molRef: 3D-PP50195
Discontinued product











